BioregulatorModerate Evidence✦ Khavinson Bioregulator

Thymogen

Also known as: Thymus dipeptide

Khavinson thymus dipeptide bioregulator for immune system regulation.

Benefits

6

Conditions

6

Evidence

Russian clinical trials, approved pharmaceutical+ studies

Source

Synthetic dipeptide thymus bioregulator

Overview

Khavinson thymus dipeptide bioregulator for immune system regulation.

Mechanism of Action

Dipeptide bioregulator for thymus and immune cells, regulates T-cell differentiation and function, modulates cytokine production, enhances cellular and humoral immunity.

Key Benefits

  • Immune system optimization
  • T-cell function enhancement
  • Cytokine regulation
  • Supports vaccine response
  • Reduces immunosenescence
  • Anti-inflammatory when needed

Clinical Applications

ImmunodeficiencyChronic infectionsAge-related immune declinePost-chemotherapy immune recoveryAutoimmune conditions (balancing)Recurrent infections

Dosing Guidelines

Topical (cream/spray)

Typical Dose0.01% solution
FrequencyOnce or twice daily
Duration10-20 days

Intranasal

Typical Dose100 mcg
FrequencyOnce daily
Duration10 days, repeat courses

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Moderate
Studies

Russian clinical trials, approved pharmaceutical

Summary

Approved pharmaceutical in Russia for immune support. Clinical trials demonstrate immune enhancement. Part of Khavinson's bioregulator pharmaceutical line.

Safety Information

Potential Side Effects

  • Minimal
  • Very well-tolerated

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • May enhance other immunotherapies

Quick Facts

CategoryBioregulator
SourceSynthetic dipeptide thymus bioregulator
Legal StatusApproved pharmaceutical in Russia; research compound elsewhere
Gabriel Brain Score
87/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.